Curis Lifesciences Limited

CURIS

Half-yearly results

standalone

Revenue and net profit

₹ crore

Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.

  • Income
  • ₹ crore

    Mar 202633

    Half year₹ croreYoY
    Sept 202528—
    Mar 202633—
  • ₹ crore

    Mar 20260.28

    Half year₹ crore
    Sept 2025<0.01
    Mar 20260.28
  • ₹ crore

    Mar 202633

    Half year₹ crore
    Sept 202528
    Mar 202633
  • Cost structure
  • ₹ crore

    Mar 20262

    Half year₹ crore
    Sept 20252
    Mar 20262
  • ₹ crore

    Mar 202629

    Half year₹ crore
    Sept 202523
    Mar 202629
  • Exceptional items and tax
  • ₹ crore

    Mar 20264

    Half year₹ crore
    Sept 20255
    Mar 20264
  • ₹ crore

    Mar 20262

    Half year₹ crore
    Sept 20251
    Mar 20262
  • Profit
  • ₹ crore

    Mar 20263

    Half year₹ croreYoY
    Sept 20254—
    Mar 20263—
  • Per share
  • ₹ per share

    Mar 20264.01

    Half year₹ per share
    Sept 20257.10
    Mar 20264.01
₹ croreSept 2025Mar 2026
Income
2833
Revenue YoY——
<0.010.28
2833
Cost structure
22
2329
Exceptional items and tax
54
12
Profit
43
Net profit YoY——
Per share
7.104.01

Latest filed period ends Mar 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 2 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.

VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.